The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

The first pill shown to treat COVID-19 has moved one step closer to being available to the public. The pharmaceutical company Merck requested FDA emergency authorization Monday for their COVID-19 ...

WASHINGTON - Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.

Though Merck is taking steps to improve access, manufacturing for low-income countries often requires WHO approval, a process which can take months Oct 17 (Reuters) - The plan to roll out Merck & Co's ...

An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP. [Reuters] Rival antiviral pills from Pfizer Inc and Merck & Co that ...

The Gazette offers audio versions of articles using Instaread. Some words may be mispronounced. WASHINGTON (AP) — In a potential leap forward in the global fight against the pandemic, drugmaker Merck ...

The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.

Merck beat first-quarter expectations and hiked its 2023 forecast even as sales plunged for its COVID-19 treatment and a strong dollar hurt revenue. Soaring sales of the drugmaker’s top seller, the ...

On Friday, Merck announced that its experimental Covid-19 pill reduced hospitalizations and deaths by 50% in people recently infected with the coronavirus, AP News reports. The drugmaker will soon ask ...